Cyclacel Pharmaceuticals Current Ratio 2006-2019 | CYCC

Cyclacel Pharmaceuticals current ratio from 2006 to 2019. Current ratio can be defined as a liquidity ratio that measures a company's ability to pay short-term obligations.
Cyclacel Pharmaceuticals Current Ratio Historical Data
Date Current Assets Current Liabilities Current Ratio
2019-03-31 $0.02B $0.00B 8.09
2018-12-31 $0.02B $0.00B 4.45
2018-09-30 $0.02B $0.00B 5.16
2018-06-30 $0.02B $0.00B 5.68
2018-03-31 $0.03B $0.00B 5.81
2017-12-31 $0.03B $0.00B 6.32
2017-09-30 $0.03B $0.00B 6.52
2017-06-30 $0.02B $0.00B 3.72
2017-03-31 $0.02B $0.00B 4.13
2016-12-31 $0.02B $0.01B 3.73
2016-09-30 $0.02B $0.01B 4.05
2016-06-30 $0.02B $0.01B 3.37
2016-03-31 $0.02B $0.01B 3.95
2015-12-31 $0.03B $0.01B 4.27
2015-09-30 $0.03B $0.01B 5.09
2015-06-30 $0.03B $0.01B 4.70
2015-03-31 $0.04B $0.01B 4.31
2014-12-31 $0.03B $0.01B 3.87
2014-09-30 $0.03B $0.01B 4.61
2014-06-30 $0.04B $0.01B 4.79
2014-03-31 $0.03B $0.01B 3.80
2013-12-31 $0.04B $0.01B 4.85
2013-09-30 $0.04B $0.01B 4.20
2013-06-30 $0.04B $0.01B 5.65
2013-03-31 $0.02B $0.01B 2.35
2012-12-31 $0.02B $0.01B 2.02
2012-09-30 $0.02B $0.01B 2.73
2012-06-30 $0.02B $0.01B 3.21
2012-03-31 $0.03B $0.01B 3.70
2011-12-31 $0.03B $0.01B 3.98
2011-09-30 $0.03B $0.01B 4.85
2011-06-30 $0.02B $0.01B 3.72
2011-03-31 $0.03B $0.01B 3.94
2010-12-31 $0.03B $0.01B 4.75
2010-09-30 $0.02B $0.01B 2.47
2010-06-30 $0.02B $0.01B 2.64
2010-03-31 $0.03B $0.01B 2.72
2009-12-31 $0.01B $0.01B 1.56
2009-09-30 $0.02B $0.01B 1.74
2009-06-30 $0.02B $0.01B 1.68
2009-03-31 $0.02B $0.01B 2.74
2008-12-31 $0.03B $0.01B 3.36
2008-09-30 $0.04B $0.01B 3.78
2008-06-30 $0.05B $0.01B 3.94
2008-03-31 $0.05B $0.01B 4.86
2007-12-31 $0.06B $0.02B 4.34
2007-09-30 $0.08B $0.01B 6.90
2007-06-30 $0.08B $0.01B 6.89
2007-03-31 $0.09B $0.01B 12.96
2006-12-31 $0.06B $0.01B 7.34
2006-09-30 $0.06B $0.01B 9.67
2006-06-30 $0.07B $0.01B 9.89
2006-03-31 $0.03B $0.01B 3.11
2005-12-31 $0.02B $0.02B 1.15
2005-09-30 $0.03B $0.01B 3.26
2005-06-30 $0.03B $0.01B 5.70
2005-03-31 $0.04B $0.01B 5.46
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $0.012B $0.000B
CYCLACEL is a biopharmaceutical company dedicated to the discovery, development and commercialization of novel, mechanism-targeted drugs to treat human cancers and other serious disorders. Three orally-available Cyclacel drugs are in clinical development. Sapacitabine, a cell cycle modulating nucleoside analog, is in Phase 2 studies for the treatment of acute myeloid leukemia in the elderly, myelodysplastic syndromes and cutaneous T-cell lymphoma. Seliciclib (CYC202 or R-roscovitine), a CDK inhibitor, is in Phase 2 for the treatment of lung cancer and nasopharyngeal cancer.
Stock Name Country Market Cap PE Ratio
Amgen (AMGN) United States $103.634B 11.72
Gilead Sciences (GILD) United States $84.602B 10.27
Celgene (CELG) United States $67.296B 11.40
Illumina (ILMN) United States $45.222B 52.41
Biogen (BIIB) United States $44.456B 8.44
Vertex Pharmaceuticals (VRTX) United States $43.215B 52.24
Regeneron Pharmaceuticals (REGN) United States $33.323B 15.66
Alexion Pharmaceuticals (ALXN) United States $29.353B 16.61
Incyte (INCY) United States $16.555B 67.13
BioMarin Pharmaceutical (BMRN) United States $15.885B 0.00
Exact Sciences (EXAS) United States $12.422B 0.00
Seattle Genetics (SGEN) United States $10.715B 0.00
Sarepta Therapeutics (SRPT) United States $9.022B 0.00
Bio-Rad Laboratories (BIO.B) United States $8.999B 47.71
QIAGEN (QGEN) Netherlands $8.360B 27.46
BeiGene (BGNE) Cayman Islands $7.863B 0.00
Moderna (MRNA) United States $7.594B 0.00
Bio-Techne Corp (TECH) United States $7.478B 51.02
Alnylam Pharmaceuticals (ALNY) United States $7.196B 0.00
Bluebird Bio (BLUE) United States $7.074B 0.00
Guardant Health (GH) United States $6.636B 0.00
Exelixis (EXEL) United States $5.833B 14.87
Galapagos (GLPG) Belgium $5.782B 0.00
Amarin (AMRN) Ireland $5.745B 0.00
Ascendis Pharma (ASND) Denmark $5.156B 0.00
Array BioPharma (ARRY) United States $4.847B 0.00
ARGENX SE-ADR (ARGX) Netherlands $4.138B 0.00
Spark Therapeutics (ONCE) United States $4.135B 0.00
Blueprint Medicines (BPMC) United States $3.972B 0.00
Alkermes (ALKS) Ireland $3.899B 0.00
China Biologic Products (CBPO) China $3.665B 23.27
ACADIA Pharmaceuticals (ACAD) United States $3.608B 0.00
Allogene Therapeutics (ALLO) United States $3.548B 0.00
Ultragenyx Pharmaceutical (RARE) United States $3.531B 0.00
Global Blood Therapeutics (GBT) United States $3.304B 0.00
MorphoSys AG Unsponsored ADR (MOR) Germany $3.275B 0.00
Repligen (RGEN) United States $3.176B 79.12
Immunomedics (IMMU) United States $2.990B 0.00
Amicus Therapeutics (FOLD) United States $2.823B 0.00
Biohaven Pharmaceutical Holding (BHVN) United States $2.744B 0.00
Reata Pharmaceuticals (RETA) United States $2.728B 0.00
Arena Pharmaceuticals (ARNA) United States $2.677B 5.44
Mirati Therapeutics (MRTX) United States $2.664B 0.00
Intercept Pharmaceuticals (ICPT) United States $2.574B 0.00
Medicines (MDCO) United States $2.438B 0.00
MyoKardia (MYOK) United States $2.287B 0.00
Emergent Biosolutions (EBS) United States $2.274B 19.75
Halozyme Therapeutics (HALO) United States $2.271B 0.00
Insmed (INSM) United States $2.263B 0.00
UniQure (QURE) Netherlands $2.258B 0.00
Ligand Pharmaceuticals (LGND) United States $2.255B 18.68
Acceleron Pharma (XLRN) United States $2.200B 0.00
NeoGenomics (NEO) United States $2.192B 143.69
CRISPR Therapeutics AG (CRSP) Switzerland $2.055B 0.00
Genomic Health (GHDX) United States $2.009B 42.66
Denali Therapeutics (DNLI) United States $1.978B 0.00
Akcea Therapeutics (AKCA) United States $1.918B 0.00
AnaptysBio (ANAB) United States $1.917B 0.00
Myriad Genetics (MYGN) United States $1.908B 18.98
Allakos (ALLK) United States $1.864B 0.00
Lion Biotechnologies (IOVA) United States $1.856B 0.00
Nabriva Therapeutics AG (NBRV) Ireland $1.798B 0.00
Audentes Therapeutics (BOLD) United States $1.743B 0.00
REGENXBIO (RGNX) United States $1.638B 0.00
Orchard Therapeutics Sponsored ADR (ORTX) United Kingdom $1.611B 0.00
Zai Lab Unsponsored ADR (ZLAB) China $1.580B 0.00
Innoviva (INVA) United States $1.478B 4.09
Cambrex (CBM) United States $1.444B 18.25
Alector (ALEC) United States $1.399B 0.00
Gossamer Bio (GOSS) United States $1.382B 0.00
Momenta Pharmaceuticals (MNTA) United States $1.303B 0.00
Coherus BioSciences (CHRS) United States $1.286B 0.00
Aimmune Therapeutics (AIMT) United States $1.257B 0.00
Rubius Therapeutics (RUBY) United States $1.253B 0.00
Fate Therapeutics (FATE) United States $1.222B 0.00
Sangamo Therapeutics (SGMO) United States $1.176B 0.00
Apellis Pharmaceuticals (APLS) United States $1.138B 0.00
Atara Biotherapeutics (ATRA) United States $1.111B 0.00
Editas Medicine (EDIT) United States $1.108B 0.00
Epizyme (EPZM) United States $1.101B 0.00
RA PHARMCTL INC (RARX) United States $1.036B 0.00
Codexis (CDXS) United States $1.036B 0.00
InflaRx (IFRX) Germany $1.035B 0.00
Eidos Therapeutics (EIDX) United States $0.983B 0.00
Athenex (ATNX) United States $0.934B 0.00
Rhythm Pharmaceuticals (RYTM) United States $0.925B 0.00
Deciphera Pharmaceuticals (DCPH) United States $0.912B 0.00
Autolus Therapeutics Sponsored ADR (AUTL) United Kingdom $0.907B 0.00
Clovis Oncology (CLVS) United States $0.905B 0.00
Alder BioPharmaceuticals (ALDR) United States $0.904B 0.00
WAVE Life Sciences (WVE) Singapore $0.898B 0.00
GENFIT Unsponsored ADR (GNFT) France $0.891B 0.00
Myovant Sciences (MYOV) United Kingdom $0.884B 0.00
Inotek Pharmaceuticals (RCKT) United States $0.879B 0.00
NGM Biopharmaceuticals (NGM) United States $0.864B 0.00
G1 THERAPEUTICS (GTHX) United States $0.847B 0.00
ANI Pharmaceuticals (ANIP) United States $0.842B 14.94
Dicerna Pharmaceuticals (DRNA) United States $0.827B 0.00
Kiniksa Pharmaceuticals (KNSA) Bermuda $0.821B 0.00
Vanda Pharmaceuticals (VNDA) United States $0.810B 38.22
Retrophin (RTRX) United States $0.788B 0.00
MeiraGTx Holdings (MGTX) United States $0.783B 0.00
Cellectis (CLLS) France $0.777B 0.00
Axsome Therapeutics (AXSM) United States $0.769B 0.00
Principia Biopharma (PRNB) United States $0.762B 0.00
Cara Therapeutics (CARA) United States $0.756B 0.00
Y-mAbs Therapeutics (YMAB) United States $0.729B 0.00
Arvinas (ARVN) United States $0.719B 0.00
Vericel (VCEL) United States $0.718B 0.00
Twist Bioscience (TWST) United States $0.718B 0.00
Nightstar Therapeutics Sponsored ADR (NITE) United Kingdom $0.716B 0.00
ZIOPHARM Oncology Inc (ZIOP) United States $0.712B 0.00
Intellia Therapeutics (NTLA) United States $0.711B 0.00
Intra-Cellular Therapies (ITCI) United States $0.690B 0.00
CORTEXYME INC (CRTX) $0.676B 0.00
Lexicon Pharmaceuticals (LXRX) United States $0.659B 0.00
Puma Biotechnology (PBYI) United States $0.641B 0.00
Stemline Therapeutics (STML) United States $0.636B 0.00
Precision BioSciences (DTIL) United States $0.628B 0.00
Kura Oncology (KURA) United States $0.614B 0.00
Zealand Pharma (ZEAL) Denmark $0.611B 7.14
Heska (HSKA) United States $0.606B 62.01
Viking Therapeutics (VKTX) United States $0.604B 0.00
Cytokineticsorporated (CYTK) United States $0.601B 0.00
ObsEva SA (OBSV) Switzerland $0.593B 0.00
Zymeworks (ZYME) Canada $0.578B 0.00
Adverum Biotechnologies (ADVM) United States $0.574B 0.00
Scholar Rock Holding (SRRK) United States $0.561B 0.00
Magenta Therapeutics (MGTA) United States $0.557B 0.00
MediciNova (MNOV) United States $0.546B 0.00
DBV Technologies (DBVT) France $0.546B 0.00
Acorda Therapeutics (ACOR) United States $0.530B 9.34
UROGEN PHARMA (URGN) United States $0.526B 0.00
Anika Therapeutics (ANIK) United States $0.525B 17.93
Revance Therapeutics (RVNC) United States $0.524B 0.00
Synthorx (THOR) United States $0.515B 0.00
Mesoblast (MESO) Australia $0.487B 0.00
CytomX Therapeutics (CTMX) United States $0.485B 0.00
Krystal Biotech (KRYS) United States $0.482B 0.00
NuCana Sponsored ADR (NCNA) United Kingdom $0.470B 0.00
Replimune (REPL) United States $0.467B 0.00
ProQR Therapeutics (PRQR) Netherlands $0.447B 0.00
Sorrento Therapeutics (SRNE) United States $0.446B 0.00
Kaleido Biosciences (KLDO) $0.442B 0.00
NEXTCURE INC (NXTC) $0.434B 0.00
Albireo Pharma (ALBO) United States $0.433B 0.00
MILESTONE PHARM (MIST) Canada $0.433B 0.00
AVROBIO (AVRO) United States $0.432B 0.00
Achillion Pharmaceuticals (ACHN) United States $0.425B 0.00
Arcus Biosciences (RCUS) United States $0.421B 0.00
Dynavax Technologies (DVAX) United States $0.410B 0.00
Cyclerion Therapeutics (CYCN) United States $0.400B 0.00
BioDelivery Sciences (BDSI) United States $0.400B 0.00
Gritstone Oncology (GRTS) United States $0.399B 0.00
Agenus (AGEN) United States $0.396B 0.00
Kezar Life Sciences (KZR) United States $0.390B 0.00
Adaptimmune Therapeutics (ADAP) United Kingdom $0.384B 0.00
Senesco Technologies (ELOX) United States $0.384B 0.00
UNITY Biotechnology (UBX) $0.383B 0.00
Stealth BioTherapeutics Sponsored ADR (MITO) United States $0.383B 0.00
Prothena (PRTA) Ireland $0.380B 0.00
Sinovac Biotech (SVA) China $0.371B 0.00
Abeona Therapeutics (ABEO) United States $0.366B 0.00
PDL BioPharma (PDLI) United States $0.363B 8.60
AMAG Pharmaceuticals (AMAG) United States $0.349B 0.00
AC Immune SA (ACIU) Switzerland $0.344B 22.13
BeyondSpring (BYSI) United States $0.342B 0.00
Kodiak Sciences (KOD) United States $0.333B 0.00
Five Prime Therapeutics (FPRX) United States $0.332B 0.00
LogicBio Therapeutics (LOGC) United States $0.332B 0.00
Biofrontera AG Sponsored ADR (BFRA) Germany $0.328B 0.00
XBiotech (XBIT) United States $0.328B 0.00
Merus (MRUS) Netherlands $0.328B 0.00
Kindred Biosciences (KIN) United States $0.328B 0.00
Inovio Pharmaceuticals (INO) United States $0.327B 0.00
AXCELLA HEALTH (AXLA) $0.317B 0.00
Cellular Biomedicine (CBMG) United States $0.305B 0.00
HOOKIPA PHARMA (HOOK) United States $0.304B 0.00
Kadmon Holdings (KDMN) United States $0.297B 0.00
Athersys (ATHX) United States $0.295B 0.00
Geron (GERN) United States $0.284B 0.00
ResTORbio (TORC) United States $0.282B 0.00
Constellation Pharmaceuticals (CNST) United States $0.274B 0.00
PHASEBIO PHARMA (PHAS) United States $0.263B 0.00
ChromaDex (CDXC) United States $0.253B 0.00
Protagonist Therapeutics (PTGX) United States $0.253B 0.00
Aduro Biotech (ADRO) United States $0.251B 0.00
Xenon Pharmaceuticals (XENE) Canada $0.246B 0.00
Evelo Biosciences (EVLO) United States $0.240B 0.00
MannKind (MNKD) United States $0.238B 0.00
Arsanis (XFOR) United States $0.232B 0.00
Celcuity (CELC) United States $0.231B 0.00
Kamada (KMDA) Israel $0.231B 8.95
Cerecor (CERC) United States $0.230B 0.00
Urovant Sciences (UROV) United States $0.224B 0.00
Sutro Biopharma (STRO) United States $0.224B 0.00
Mersana Therapeutics (MRSN) United States $0.223B 0.00
Enochian BioSciences (ENOB) United States $0.221B 0.00
Syros Pharmaceuticals (SYRS) United States $0.220B 0.00
OvaScience (MLND) United States $0.220B 0.00
Eiger BioPharmaceuticals (EIGR) United States $0.214B 0.00
Solid Biosciences (SLDB) United States $0.214B 0.00
TOCAGEN INC (TOCA) United States $0.211B 0.00
Spero Therapeutics (SPRO) United States $0.210B 0.00
Affimed (AFMD) Germany $0.210B 0.00
Synlogic (SYBX) United States $0.208B 0.00
Kala Pharmaceuticals (KALA) United States $0.202B 0.00
Syndax Pharmaceuticals (SNDX) United States $0.199B 0.00
VBI Vaccines (VBIV) United States $0.198B 0.00
Neothetics (EVFM) United States $0.198B 0.00
EYEPOINT PHARMACEUTICALS, INC (EYPT) United States $0.196B 0.00
Avid Bioservices (CDMO) United States $0.196B 0.00
Chiasma (CHMA) United States $0.190B 0.00
Celyad SA (CYAD) Belgium $0.189B 0.00
Aeglea BioTherapeutics (AGLE) United States $0.187B 0.00
ADMA Biologics Inc (ADMA) United States $0.187B 0.00
Liquidia Technologies (LQDA) United States $0.183B 0.00
Gamida Cell (GMDA) Israel $0.181B 0.00
Compugen (CGEN) Israel $0.177B 0.00
Pieris Pharmaceuticals (PIRS) United States $0.176B 0.00
Cue Biopharma (CUE) United States $0.175B 0.00
Intec Pharma (NTEC) Israel $0.174B 0.00
Enzo Biochem (ENZ) United States $0.172B 0.00
BioXcel Therapeutics (BTAI) United States $0.171B 0.00
Anavex Life Sciences (AVXL) United States $0.170B 0.00
Seres Therapeutics (MCRB) United States $0.170B 0.00
Axovant Sciences (AXGT) United Kingdom $0.168B 0.00
Menlo Therapeutics (MNLO) United States $0.165B 0.00
Mustang Bio (MBIO) United States $0.164B 0.00
Strongbridge Biopharma (SBBP) United States $0.164B 9.47
Checkpoint Therapeutics (CKPT) United States $0.158B 0.00
Paratek Pharmaceuticals (PRTK) United States $0.147B 0.00
Eton Pharmaceuticals (ETON) United States $0.146B 0.00
Provention Bio (PRVB) United States $0.146B 0.00
XOMA (XOMA) United States $0.141B 0.00
OSMOTICA PHARM (OSMT) United States $0.139B 0.00
Novavax (NVAX) United States $0.138B 0.00
Arbutus Biopharma (ABUS) Canada $0.136B 0.00
TREVI THERAPTCS (TRVI) United States $0.136B 0.00
Erytech Pharma SA Sponsored ADR (ERYP) France $0.129B 0.00
Trevena (TRVN) United States $0.125B 0.00
Fortress Biotech (FBIO) United States $0.124B 0.00
Corvus Pharmaceuticals (CRVS) United States $0.120B 0.00
Organovo Holdings (ONVO) United States $0.118B 0.00
Aptinyx (APTX) United States $0.118B 0.00
ASLAN Pharmaceuticals (ASLN) Singapore $0.115B 0.00
AVEO Pharmaceuticals (AVEO) United States $0.114B 0.00
Spring Bank Pharmaceuticals (SBPH) United States $0.114B 0.00
Verastem (VSTM) United States $0.113B 0.00
SESEN BIO, INC (SESN) United States $0.112B 0.00
INmune Bio (INMB) United States $0.111B 0.00
Dyadic (DYAI) United States $0.111B 0.00
Nymox Pharmaceutical (NYMX) Canada $0.110B 0.00
Allena Pharmaceuticals (ALNA) United States $0.109B 0.00
Tiziana Life Sciences Sponsored ADR (TLSA) United Kingdom $0.107B 0.00
Equillium (EQ) United States $0.107B 0.00
NantKwest (NK) United States $0.104B 0.00
Unum Therapeutics (UMRX) United States $0.102B 0.00
Catalyst Biosciences (CBIO) United States $0.101B 0.00
Selecta Biosciences (SELB) United States $0.100B 0.00
Pluristem Therapeutics (PSTI) Israel $0.093B 0.00
Catabasis Pharmaceuticals (CATB) United States $0.092B 0.00
Cohbar (CWBR) United States $0.087B 0.00
Signal Genetics (MGEN) United States $0.087B 0.00
Aptose Biosciences (APTO) Canada $0.087B 0.00
Sunesis Pharmaceuticals (SNSS) United States $0.085B 0.00
Brainstorm Cell Therapeutics (BCLI) United States $0.084B 0.00
ANIXA BIOSCIENCES INC (ANIX) United States $0.084B 0.00
Cocrystal Pharma (COCP) United States $0.081B 85.00
Merrimack Pharmaceuticals (MACK) United States $0.080B 0.00
VTv Therapeutics (VTVT) United States $0.080B 0.00
Vaccinex (VCNX) United States $0.079B 0.00
Verona Pharma American Depositary Share (VRNA) United Kingdom $0.078B 0.00
Aridis Pharmaceuticals (ARDS) United States $0.076B 0.00
ARAVIVE, INC (ARAV) United States $0.072B 0.00
Idera Pharmaceuticals (IDRA) United States $0.071B 0.00
Orgenesis (ORGS) United States $0.070B 0.00
Applied Genetic Technologies (AGTC) United States $0.069B 38.20
OVID THERAPEUTC (OVID) United States $0.068B 0.00
Alcobra (ARCT) United States $0.067B 0.00
Prima BioMed (IMMP) Australia $0.066B 0.00
ScPharmaceuticals (SCPH) United States $0.065B 0.00
Alimera Sciences (ALIM) United States $0.065B 0.00
Eyenovia (EYEN) United States $0.062B 0.00
NewLink Genetics (NLNK) United States $0.059B 0.00
Proteostasis Therapeutics (PTI) United States $0.058B 0.00
Ophthotech (ISEE) United States $0.056B 0.00
INNOVATE BIOPHARMACEUTICALS, INC (INNT) United States $0.056B 0.00
Apricus Biosciences (SEEL) United States $0.055B 0.00
Curis (CRIS) United States $0.054B 0.00
AZURRX BIOPHARM (AZRX) United States $0.054B 0.00
Cidara Therapeutics (CDTX) United States $0.054B 0.00
Zosano Pharma (ZSAN) United States $0.053B 0.00
Moleculin Biotech (MBRX) United States $0.052B 0.00
AEterna Zentaris (AEZS) United States $0.052B 0.00
Hoth Therapeutics (HOTH) United States $0.052B 0.00
Bellerophon Therapeutics (BLPH) United States $0.046B 0.00
Clearside Biomedical (CLSD) United States $0.046B 0.00
AquaBounty Technologies (AQB) United States $0.046B 0.00
Entera Bio (ENTX) Israel $0.046B 0.00
Vascular Biogenics (VBLT) Israel $0.045B 0.00
Evogene (EVGN) Israel $0.045B 0.00
Celsion (CLSN) United States $0.044B 0.00
Akari Therapeutics (AKTX) United Kingdom $0.044B 0.00
Celldex Therapeutics (CLDX) United States $0.043B 0.00
BiondVax Pharmaceuticals (BVXV) Israel $0.042B 0.00
VIVUS (VVUS) United States $0.042B 0.00
Aerpio Pharmaceuticals (ARPO) United States $0.041B 0.00
Sienna Biopharmaceuticals (SNNA) United States $0.041B 0.00
Anchiano Therapeutics Sponsored ADR (ANCN) Israel $0.039B 0.00
Aptevo Therapeutics (APVO) United States $0.036B 0.00
Oncolytics Biotech (ONCY) Canada $0.035B 0.00
Bionano Genomics (BNGO) United States $0.034B 0.00
Leap Therapeutics (LPTX) United States $0.034B 0.00
VistaGen Therapeutics (VTGN) United States $0.032B 0.00
DiaMedica Therapeutics (DMAC) United States $0.032B 0.00
Caladrius Biosciences (CLBS) United States $0.031B 0.00
OncoSec Medical (ONCS) United States $0.029B 0.00
Motif Bio Plc (MTFB) United States $0.028B 0.00
GENPREX INC (GNPX) United States $0.028B 0.00
Vical (VICL) United States $0.026B 0.00
GTx (GTXI) United States $0.025B 0.00
Oncobiologics (OTLK) United States $0.025B 0.00
TRACON Pharmaceuticals (TCON) United States $0.024B 0.00
Aytu Bioscience (AYTU) United States $0.024B 0.00
Sophiris Bio (SPHS) United States $0.024B 0.00
Adial Pharmaceuticals (ADIL) United States $0.023B 0.00
Novelion Therapeutics (NVLN) Canada $0.023B 0.00
ATyr Pharma (LIFE) United States $0.021B 0.00
Benitec Biopharma (BNTC) Australia $0.020B 0.00
Galena Biopharma (SLS) United States $0.020B 0.00
Titan Pharmaceuticals (TTNP) United States $0.020B 0.00
Fibrocell Science Inc (FCSC) United States $0.019B 0.00
CytRx (CYTR) United States $0.019B 0.00
Aileron Therapeutics (ALRN) United States $0.018B 0.00
Cleveland BioLabs (CBLI) United States $0.018B 0.00
Genetic Technologies (GENE) Australia $0.018B 0.00
IMMURON LTD (IMRN) Australia $0.018B 0.00
Advaxis (ADXS) United States $0.017B 0.00
Histogenics (HSGX) United States $0.016B 0.00
Gemphire Therapeutics (GEMP) United States $0.016B 0.00
TrovaGene (TROV) United States $0.015B 0.00
Novogen (KZIA) Australia $0.015B 0.00
RestorGenex (DFFN) United States $0.015B 0.00
Prana Biotechnology (ATHE) Australia $0.014B 0.00
Soligenix (SNGX) United States $0.012B 0.00
Therapix Biosciences (TRPX) Israel $0.012B 5.82
MYOS RENS Technology (MYOS) United States $0.012B 0.00
Edge Therapeutics (PDSB) United States $0.011B 0.00
Vital Therapies (IMUX) United States $0.011B 0.00
ARCA Biopharma (ABIO) United States $0.010B 0.00
Dare Bioscience (DARE) United States $0.010B 0.00
Neuralstem (CUR) United States $0.009B 0.00
Tenax Therapeutics (TENX) United States $0.008B 0.00
Pulmatrix (PULM) United States $0.008B 0.00
Flex Pharma (FLKS) United States $0.008B 0.00
Proteon Therapeutics (PRTO) United States $0.007B 0.00
Alliqua BioMedical (ADYX) United States $0.006B 0.00
Stellar Biotechnologies (SBOT) United States $0.006B 0.00
Cytori Therapeutics Inc (CYTX) United States $0.004B 0.00
Cellect Biotechnology (APOP) Israel $0.003B 0.00
ContraVir Pharmaceuticals Inc (CTRV) United States $0.002B 0.00
Horizon Pharma Public (HZNP) Ireland $0.000B 0.00